Calculating The Intrinsic Value Of Boiron SA (EPA:BOI)
Jan 26
French (CAC) Pharma Industry Analysis
UpdatedJan 30, 2023
DataAggregated Company Financials
Companies8
- 7D-1.3%
- 3M1.8%
- 1Y-4.4%
- YTD-2.0%
Over the last 7 days, the Pharma industry has dropped 1.3%, driven by a pullback from Sanofi of 1.3%. Overall the industry is down 4.4% in 12 months. Looking forward, earnings are forecast to grow by 11% annually.
Industry Valuation and Performance
Has the French Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 30 Jan 2023 | €125.4b | €50.7b | €7.4b | 18.7x | 17x | 2.5x |
| Wed, 28 Dec 2022 | €127.7b | €50.7b | €7.4b | 17.3x | 17.4x | 2.5x |
| Fri, 25 Nov 2022 | €123.8b | €50.7b | €7.4b | 17.4x | 16.8x | 2.4x |
| Sun, 23 Oct 2022 | €116.3b | €48.4b | €7.6b | 16.5x | 15.3x | 2.4x |
| Tue, 20 Sep 2022 | €114.8b | €48.4b | €7.6b | 17.8x | 15.1x | 2.4x |
| Thu, 18 Aug 2022 | €117.3b | €48.2b | €7.6b | 23.7x | 15.5x | 2.4x |
| Sat, 16 Jul 2022 | €139.8b | €46.3b | €7.5b | 23.4x | 18.7x | 3x |
| Mon, 13 Jun 2022 | €134.7b | €46.3b | €7.5b | 21.8x | 18x | 2.9x |
| Wed, 11 May 2022 | €136.3b | €45.4b | €7.5b | 22x | 18.1x | 3x |
| Fri, 08 Apr 2022 | €139.8b | €44.2b | €7.1b | 23.2x | 19.8x | 3.2x |
| Sun, 06 Mar 2022 | €123.1b | €44.1b | €7.1b | 18.2x | 17.4x | 2.8x |
| Tue, 01 Feb 2022 | €128.9b | €43.2b | €7.0b | 18.9x | 18.4x | 3x |
| Thu, 30 Dec 2021 | €124.1b | €43.2b | €7.0b | 22.4x | 17.7x | 2.9x |
| Sat, 27 Nov 2021 | €120.1b | €43.2b | €7.0b | 21.1x | 17.2x | 2.8x |
| Mon, 25 Oct 2021 | €120.1b | €42.3b | €6.6b | 19.9x | 18.2x | 2.8x |
| Wed, 22 Sep 2021 | €116.0b | €42.2b | €6.6b | 24.2x | 17.6x | 2.7x |
| Fri, 20 Aug 2021 | €126.5b | €42.2b | €6.6b | 21.7x | 19.2x | 3x |
| Fri, 04 Jun 2021 | €120.3b | €41.6b | €12.9b | 16.4x | 9.3x | 2.9x |
| Mon, 08 Mar 2021 | €105.0b | €41.9b | €13.0b | 12.4x | 8.1x | 2.5x |
| Thu, 10 Dec 2020 | €116.7b | €42.2b | €11.6b | 20.3x | 10x | 2.8x |
| Wed, 02 Sep 2020 | €116.9b | €42.3b | €11.2b | 18.5x | 10.4x | 2.8x |
| Sat, 06 Jun 2020 | €118.5b | €42.8b | €3.5b | 24.4x | 33.7x | 2.8x |
| Tue, 10 Mar 2020 | €113.3b | €42.2b | €3.0b | 31x | 38.4x | 2.7x |
Price to Earnings Ratio
39.9x
Current Industry PE
- Investors are relatively neutral on the French Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 17.4x.
- The 3-year average PS ratio of 2.8x is higher than the industry's current PS ratio of 2.5x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 36% per year over the last three years.
- Revenues for these companies have grown 6.3% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the French Healthcare industry?
| FR Market | 1.41% | |
| Healthcare | -1.57% | |
| Pharma | -1.27% | |
| Pharma | -1.27% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| VIRP Virbac | €281.00 | 2.6% +€59.2m | -21.0% | PE20x | |
| BOI Boiron | €43.45 | 2.5% +€18.2m | 7.5% | PE14.9x | |
| VETO Vetoquinol | €88.00 | 1.7% +€17.7m | -32.2% | PE21.7x | |
| MEDCL MedinCell | €8.05 | 4.8% +€9.3m | 1.1% | PS23.7x | |
| ALTHX Theranexus Société Anonyme | €1.95 | 1.2% +€128.3k | -43.1% | PS25.4x |